MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD

Neurology

Volumn 60, Issue 2, 2003, Pages 253-260

  Jack Jr , C R ^a   Slomkowski, M ^b   Gracon, S ^b   Hoover, T M ^b   Felmlee, J P ^a   Stewart, K ^a   Xu, Y ^a   Shiung, M ^a   O'Brien, P C ^a   Cha, R ^a   Knopman, D ^a   Petersen, R C ^a  

^a MAYO CLINIC   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILAMELINE; MUSCARINIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; BRAIN SIZE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TASK PERFORMANCE; TEMPORAL CORTEX; TREATMENT OUTCOME;

EID: 0037469189     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000042480.86872.03     Document Type: Article

References (24)

1. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 1997;7:1069-1075.
2. Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 1999;52:1687-1689.
3. Fox NC, Freeborough PA, Rossor MN. Visualization and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-97.
4. Fox NC, Cousens S, Scahill R, et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease. Arch Neurol 2000;57:339-443.
5. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997;15:623-629.
6. Jack CR Jr, Petersen RC, Xu Y, et al. The rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998;51:993-999.
7. Jack CR Jr, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy in normal aging, mild cognitive impairment, and Alzheimer's disease. Neurology 2000;55:484-489.
8. Perry E, Tomlinson B, Blessed G, Bergmann K, Givson P, Perry R. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 1978;2:1457-1459.
9. Whitehouse PJ, Price DL, Strubel RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-1239.
10. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
11. Felmlee JP, Lanners DM, Rettman DW, Hangiandreou NJ, Jack CRJ. MR imaging quality control measurements taken as part of a multicenter trial: initial results. Radiology 1997;205:619.
12. Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
13. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
14. Jack CR Jr, Twomey CK, Zinsmeister AR, et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements for MR images in young adults. Radiology 1989;172:549-554.
15. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of hippocampal formation. Radiology 1990;175:423-429.
16. Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
17. Krasuski JS, Alexander GE, Horwitz B, et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 1998;43:60-68.
18. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73-86.
19. Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:927-937.
20. Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-408.
21. Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H. Hippocampus in Alzheimer's disease: a 3-year followup MRI study. Biol Psychiatry 2000;47:557-561.
22. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain 1996;119:2001-2007.
23. Petersen RC, Jack CR Jr, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and Alzheimer's disease. Neurology 2000;54:581-587.
24. DeCarli C, Haxby JV, Gillette JA, et al. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology 1993;42:2029-2036.